Sowalsky, A. G., Ye, H., Bhasin, M., Van Allen, E. M., Loda, M., Lis, R. T., . . . Balk, S. P. (2018). Neoadjuvant-intensive androgen deprivation therapy selects for prostate tumor foci with diverse subclonal oncogenic alterations. Cancer Res.
استشهاد بنمط شيكاغوSowalsky, Adam G., et al. "Neoadjuvant-intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci With Diverse Subclonal Oncogenic Alterations." Cancer Res 2018.
MLA استشهادSowalsky, Adam G., et al. "Neoadjuvant-intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci With Diverse Subclonal Oncogenic Alterations." Cancer Res 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.